Search filters

List of works by Vivek Subbiah

223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy

scientific article published on 01 April 2020

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

Advances in Targeting RET-Dependent Cancers

scientific article published on 24 February 2020

Artificial Intelligence Systems Assisting Oncologists? Resist and Desist or Enlist and Coexist

scientific article published on 23 July 2019

Cancer Genetics and Therapeutic Opportunities in Urologic Practice

scientific article published on 18 March 2020

Cancer-Related Internet Use and its Association with Patient Decision Making and Trust in Physicians among Patients in an Early Drug Development Clinic (Preprint)

article

Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer

scientific article published on 18 December 2019

Characteristics and outcomes of patients with advanced sarcoma enrolled in early phase immunotherapy trials.

scientific article published on 19 December 2017

Comprehensive molecular imaging of malignant transformation of giant cell tumour of bone reveals diverse disease biology

scientific article published on 23 April 2019

Defining Clinical Response Criteria and Early Response Criteria for Precision Oncology: Current State-of-the-Art and Future Perspectives.

scientific article published on 15 February 2017

Development of sodium fluoride PET response criteria for solid tumours (NAFCIST) in a clinical trial of radium-223 in osteosarcoma: from RECIST to PERCIST to NAFCIST

article

Dual EGFR blockade with cetuximab and erlotinib combined with anti-VEGF antibody bevacizumab in advanced solid tumors: a phase 1 dose escalation triplet combination trial

scientific article published on 20 April 2020

Dual inhibition of BRAF and mTOR in BRAF V600E -mutant pediatric, adolescent, and young adult brain tumors

scientific article published on 25 August 2020

Early Response Assessment to Targeted Therapy Using 3'-deoxy-3'[(18)F]-Fluorothymidine (18F-FLT) PET/CT in Lung Cancer

scientific article published on 06 January 2020

Efficacy of Selpercatinib in RET Fusion-Positive Non-Small-Cell Lung Cancer

scientific article published on 01 August 2020

Efficacy of Selpercatinib in RET-Altered Thyroid Cancers

scientific article published on 01 August 2020

Genomics, morphoproteomics, and treatment patterns of alveolar soft part sarcoma patients and response to multiple experimental therapies

scientific article published on 03 March 2020

Higher mortality in men from COVID19 infection-understanding the factors that drive the differences between the biological sexes

scientific article published on 24 April 2020

IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers

scientific article published on 02 July 2020

Immunotherapy and next-generation sequencing guided therapy for precision oncology: What have we learnt and what does the future hold?

scientific article published on 18 June 2018

Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trials

scientific article published on 01 December 2018

MAGE-A3 is a Clinically Relevant Target in Undifferentiated Pleomorphic Sarcoma/Myxofibrosarcoma

scientific article published on 15 May 2019

Managing Cancer Care during the COVID-19 Pandemic and Beyond

scientific article published on 27 April 2020

Mining Public Databases for Precision Oncology

scientific article published on 22 May 2018

Molecular Imaging with 3'-deoxy-3'[(18)F]-Fluorothymidine (18F-FLT) PET/CT for Early Response to Targeted Therapies in Sarcomas: A Pilot Study

scientific article published on 25 February 2020

Molecular imaging of metastatic atrial angiosarcoma with positron emission tomography (PET) tracer 3'-deoxy-3'[(18)F]-fluorothymidine, [(18)F]-FLT imaging and early response evaluation

scientific article published on 06 May 2019

Molecular profiling of metastatic bladder cancer early-phase clinical trial participants predicts patient outcomes

scientific article published on 15 December 2020

Mycobacterial infections due to PD-1 and PD-L1 checkpoint inhibitors

scientific article published on 01 August 2020

Novel use of a Clinical Laboratory Improvements Amendments (CLIA)-certified Cyclin-Dependent Kinase N2C (CDKN2C) loss assay in sporadic medullary thyroid carcinoma

scientific article published on 21 October 2019

Of mice and men: lost in translation

scientific article published on 01 April 2019

Outcomes of patients with sarcoma enrolled in clinical trials of pazopanib combined with histone deacetylase, mTOR, Her2, or MEK inhibitors.

scientific article

Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers

scientific article published on 06 February 2020

Pearls and pitfalls of ChatGPT in medical oncology

scientific article published in 2023

Phase 1 Study of P-cadherin-Targeted Radioimmunotherapy with 90Y-FF-21101 Monoclonal Antibody in Solid Tumors

scientific article published on 18 August 2020

Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies

scientific article published in 2021

Phase I studies of vorinostat with ixazomib or pazopanib imply a role of antiangiogenesis-based therapy for TP53 mutant malignancies

scientific article published on 20 February 2020

Phase I study of everolimus, letrozole, and trastuzumab in patients with hormone receptor-positive metastatic breast cancer or other solid tumors

scientific article published on 28 October 2020

Phase II Clinical Trial of Pembrolizumab in Patients with Progressive Metastatic Pheochromocytomas and Paragangliomas

scientific article published on 16 August 2020

Progresses toward precision medicine in RET-altered solid tumors

scientific article published on 14 July 2020

Responsiveness to immune checkpoint inhibitors versus other systemic therapies in RET-aberrant malignancies

scientific article published on 01 October 2020

Safety and Efficacy of Vorinostat Plus Sirolimus or Everolimus in Patients with Relapsed Refractory Hodgkin Lymphoma

scientific article published on 14 October 2020

Selective RET kinase inhibition for patients with RET-altered cancers.

scientific article published in August 2018

The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations

scientific article published in 2022

Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor

scientific article published on 01 August 2018

Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials

scientific article published on 16 September 2020

Unique Aberrations in Intimal Sarcoma Identified by Next-Generation Sequencing as Potential Therapy Targets

scientific article published on 31 August 2019

Validation of prognostic scoring systems for patients with metastatic renal cell carcinoma enrolled in phase I clinical trials

scientific article published on 01 November 2020

Paulina is supported by:

About Paulina

Help